Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 198

1.

Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.

Du G, Lewis MM, Styner M, Shaffer ML, Sen S, Yang QX, Huang X.

Mov Disord. 2011 Aug 1;26(9):1627-32. doi: 10.1002/mds.23643. Epub 2011 May 26.

PMID:
21618607
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.

Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U.

Brain. 2010 Nov;133(11):3423-33. doi: 10.1093/brain/awq212. Epub 2010 Aug 23.

PMID:
20736190
[PubMed - indexed for MEDLINE]
Free Article
3.

Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.

Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, Seppi K.

Brain. 2013 Oct;136(Pt 10):3028-37. doi: 10.1093/brain/awt234. Epub 2013 Sep 6.

PMID:
24014521
[PubMed - indexed for MEDLINE]
4.

Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.

Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, Robertson HA.

J Neurol. 2011 Jul;258(7):1254-60. doi: 10.1007/s00415-011-5915-2. Epub 2011 Feb 3.

PMID:
21287185
[PubMed - indexed for MEDLINE]
5.

T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.

Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP.

Mov Disord. 2011 Aug 1;26(9):1633-8. doi: 10.1002/mds.23722. Epub 2011 Apr 12. Erratum in: Mov Disord. 2012 Feb;27(2):335.

PMID:
21491489
[PubMed - indexed for MEDLINE]
6.

Imaging nigral pathology and clinical progression in Parkinson's disease.

Du G, Lewis MM, Sen S, Wang J, Shaffer ML, Styner M, Yang QX, Huang X.

Mov Disord. 2012 Nov;27(13):1636-43. doi: 10.1002/mds.25182. Epub 2012 Sep 24.

PMID:
23008179
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging.

Zhan W, Kang GA, Glass GA, Zhang Y, Shirley C, Millin R, Possin KL, Nezamzadeh M, Weiner MW, Marks WJ Jr, Schuff N.

Mov Disord. 2012 Jan;27(1):90-7. doi: 10.1002/mds.23917. Epub 2011 Aug 17.

PMID:
21850668
[PubMed - indexed for MEDLINE]
8.

Case control study of diffusion tensor imaging in Parkinson's disease.

Chan LL, Rumpel H, Yap K, Lee E, Loo HV, Ho GL, Fook-Chong S, Yuen Y, Tan EK.

J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1383-6. Epub 2007 Jul 5.

PMID:
17615165
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Magnetic resonance imaging of the substantia nigra in Parkinson's disease.

Lehéricy S, Sharman MA, Dos Santos CL, Paquin R, Gallea C.

Mov Disord. 2012 Jun;27(7):822-30. doi: 10.1002/mds.25015. Epub 2012 May 30. Review.

PMID:
22649063
[PubMed - indexed for MEDLINE]
10.

Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.

Prakash BD, Sitoh YY, Tan LC, Au WL.

Parkinsonism Relat Disord. 2012 Nov;18(9):1029-33. doi: 10.1016/j.parkreldis.2012.05.021. Epub 2012 Jun 16.

PMID:
22705126
[PubMed - indexed for MEDLINE]
11.

Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging.

Adachi M, Hosoya T, Haku T, Yamaguchi K, Kawanami T.

AJNR Am J Neuroradiol. 1999 Sep;20(8):1500-6.

PMID:
10512237
[PubMed - indexed for MEDLINE]
Free Article
12.

A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging.

Nair SR, Tan LK, Mohd Ramli N, Lim SY, Rahmat K, Mohd Nor H.

Eur Radiol. 2013 Jun;23(6):1459-66. doi: 10.1007/s00330-012-2759-9. Epub 2013 Jan 10.

PMID:
23300042
[PubMed - indexed for MEDLINE]
13.

Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.

Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, Auer DP.

Neuroimage Clin. 2013 Oct 14;3:481-8. doi: 10.1016/j.nicl.2013.10.006. eCollection 2013.

PMID:
24273730
[PubMed]
Free PMC Article
14.

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.

Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C.

Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.

PMID:
21109502
[PubMed - indexed for MEDLINE]
Free Article
15.

Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.

Wang C, Fan G, Xu K, Wang S.

Magn Reson Imaging. 2013 Sep;31(7):1068-73. doi: 10.1016/j.mri.2013.04.015. Epub 2013 Jun 6.

PMID:
23746648
[PubMed - indexed for MEDLINE]
16.

High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease.

Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Schäfer A, Peters AM, Bowtell RW, Auer DP, Gowland PA, Bajaj NP.

J Magn Reson Imaging. 2012 Jan;35(1):48-55. doi: 10.1002/jmri.22752. Epub 2011 Oct 10.

PMID:
21987471
[PubMed - indexed for MEDLINE]
17.

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.

Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM.

Neurology. 2009 Apr 21;72(16):1378-84. doi: 10.1212/01.wnl.0000340982.01727.6e. Epub 2009 Jan 7. Erratum in: Neurology. 2009 Jun 9;72(23):2059.

PMID:
19129507
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.

Skorpil M, Söderlund V, Sundin A, Svenningsson P.

J Parkinsons Dis. 2012;2(2):171-80. doi: 10.3233/JPD-2012-12091.

PMID:
23939442
[PubMed - indexed for MEDLINE]
19.

Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.

Gröger A, Chadzynski G, Godau J, Berg D, Klose U.

Eur Radiol. 2011 Sep;21(9):1962-9. doi: 10.1007/s00330-011-2123-5. Epub 2011 Apr 12.

PMID:
21484351
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk